GlaxoSmithKline Pakistan (KAR:GLAXO) EPS (Basic) : ₨14.16 (TTM As of Sep. 2024)

View and export this data going back to 1953. Start your Free Trial

What is GlaxoSmithKline Pakistan EPS (Basic)?

GlaxoSmithKline Pakistan's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ₨6.05. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ₨14.16.

GlaxoSmithKline Pakistan's EPS (Diluted) for the three months ended in Sep. 2024 was ₨6.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₨14.16.

GlaxoSmithKline Pakistan's EPS without NRI for the three months ended in Sep. 2024 was ₨6.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 14.52.

During the past 12 months, GlaxoSmithKline Pakistan's average EPS without NRIGrowth Rate was 267.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was -43.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -21.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, GlaxoSmithKline Pakistan's highest 3-Year average EPS without NRI Growth Rate was 32.50% per year. The lowest was -43.00% per year. And the median was 6.70% per year.

GlaxoSmithKline Pakistan EPS (Basic) Historical Data

The historical data trend for GlaxoSmithKline Pakistan's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pakistan EPS (Basic) Chart

GlaxoSmithKline Pakistan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

9.55

10.60

16.81

7.73

1.68

GlaxoSmithKline Pakistan Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-0.22	2.91	1.78	3.42	6.05

GlaxoSmithKline Pakistan EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

GlaxoSmithKline Pakistan's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(533.953	-	0)	/	318.467
	=	1.68

GlaxoSmithKline Pakistan's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1927.134	-	0)	/	318.535
	=	6.05

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨14.16

GlaxoSmithKline Pakistan (KAR:GLAXO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

GlaxoSmithKline Pakistan EPS (Basic) Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pakistan's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pakistan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pakistan Ltd (KAR:GLAXO) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

35, Dockyard Road, West Wharf, Karachi, PAK, 74000

Website

https://www.pk.gsk.com

GlaxoSmithKline Pakistan Ltd is engaged in research, development, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company derives maximum revenue from Pharmaceuticals segment.

GlaxoSmithKline Pakistan Headlines

No Headlines